Courage Therapeutics, Inc.

Biotechnology company · Newton, Massachusetts, United States

Courage Therapeutics, Inc. is a biotechnology company headquartered in Newton, Massachusetts, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $2.2 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $4.5 million sold in a notice filed in 2025.

www.couragetx.comProfile compiled from public records. Is this your company? Request a correction or update

Courage Therapeutics at a glance

Typebiotechnology company
HeadquartersNewton, Massachusetts, United States
Employees (self-reported, 2022)2
SEC CIK2069873

What does Courage Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $2.2 million in total (2020 to 2022). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Mental Health.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $4.5 million sold (2025).

Frequently asked questions about Courage Therapeutics

Where is Courage Therapeutics headquartered?

Courage Therapeutics, Inc. is headquartered in Newton, Massachusetts, United States.

What does Courage Therapeutics do?

Courage Therapeutics, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences